Port Capital LLC Takes Position in Revvity Inc. $RVTY

Port Capital LLC acquired a new position in shares of Revvity Inc. (NYSE:RVTY) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 85,992 shares of the company’s stock, valued at approximately $9,567,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Ascentis Independent Advisors bought a new stake in shares of Revvity in the first quarter valued at about $29,000. CYBER HORNET ETFs LLC bought a new position in Revvity during the second quarter worth about $32,000. MUFG Securities EMEA plc bought a new position in Revvity during the second quarter worth about $34,000. SJS Investment Consulting Inc. raised its stake in Revvity by 5,210.0% in the 1st quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after purchasing an additional 521 shares in the last quarter. Finally, Headlands Technologies LLC acquired a new stake in Revvity in the 2nd quarter worth about $49,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on RVTY. Zacks Research raised shares of Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Weiss Ratings raised shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 30th. JPMorgan Chase & Co. dropped their price target on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Wall Street Zen cut Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. Finally, Barclays increased their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Three research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $108.36.

Revvity Trading Up 1.2%

RVTY opened at $126.31 on Thursday. The stock has a market capitalization of $14.09 billion, a price-to-earnings ratio of 60.15, a P/E/G ratio of 2.27 and a beta of 1.07. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $126.90. The company has a 50-day simple moving average of $112.94 and a 200 day simple moving average of $100.82.

Revvity (NYSE:RVTY) last released its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm had revenue of $729.69 million for the quarter, compared to analyst estimates of $702.96 million. During the same period last year, the firm earned $1.18 EPS. The business’s quarterly revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Analysts predict that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. Revvity’s dividend payout ratio (DPR) is currently 13.33%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.